Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
Pharmex Middle EastPharmex Middle East
Not Confirmed
Not Confirmed
26-28 May, 2026
Not Confirmed
Not Confirmed
27-28 May, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
Pharmex Middle EastPharmex Middle East
Industry Trade Show
Not Confirmed
26-28 May, 2026
Industry Trade Show
Not Confirmed
27-28 May, 2026
Digital content

07 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/07/3289917/0/en/praxis-precision-medicines-provides-corporate-update-and-reports-first-quarter-2026-financial-results.html

04 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/04/3287106/0/en/praxis-precision-medicines-to-report-first-quarter-2026-financial-results-on-thursday-may-7-2026-and-participate-in-upcoming-investor-conference.html

14 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/14/3273225/0/en/Praxis-Precision-Medicines-Announces-FDA-Acceptance-of-New-Drug-Application-for-Ulixacaltamide-HCl-in-Patients-with-Essential-Tremor.html

13 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/13/3272452/0/en/Praxis-to-Showcase-Essential3-the-First-Positive-Phase-3-Program-in-Essential-Tremor-at-AAN-2026.html

06 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/06/3268372/0/en/Praxis-Precision-Medicines-Announces-Positive-Results-from-the-EMBRAVE-Part-A-Trial-of-Elsunersen-in-Patients-with-SCN2A-Early-Onset-Developmental-and-Epileptic-Encephalopathy.html

02 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/02/3267813/0/en/Praxis-Precision-Medicines-Inc-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
ABOUT THIS PAGE